Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 4,674 | 7,203 | 6,878 | 5,187 | 5,554 |
| Cost of Goods | 4,342 | 5,568 | 3,906 | 1,955 | 2,209 |
| Gross Profit | 332 | 1,635 | 2,972 | 3,232 | 3,345 |
| Operating Expenses | 5,366 | 5,854 | 5,005 | 5,787 | 4,407 |
| Operating Income | -5,034 | -4,219 | -2,033 | -2,555 | -1,062 |
| Interest Expense | N/A | N/A | N/A | N/A | 101 |
| Other Income | 154 | 225 | -336 | -85 | -232 |
| Pre-tax Income | -4,880 | -3,994 | -2,369 | -2,640 | -1,395 |
| Income Tax | -560 | -702 | 230 | -108 | 97 |
| Net Income Continuous | -4,320 | -3,292 | -2,599 | -2,532 | -1,492 |
| Minority Interests | 365 | N/A | 134 | 236 | 42 |
| Net Income | $-3,955 | $-3,704 | $-2,465 | $-2,296 | $-1,450 |
| EPS Basic Total Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| EBITDA(a) | $-3,808 | $-2,959 | $-931 | $-1,359 | $-203 |